Kaneka Corporation wins Ingredient of the Year: Healthspan Award

Kaneka Corporation, the global leader in Ubiquinol, has once again been recognized for its groundbreaking research and innovation in mitochondrial health with the Ingredient of the Year: Healthspan Award at the NutraIngredients-Asia Awards 2026.

This accolade marks the company's third consecutive win at the NutraIngredients-Asia Awards, following its Healthy Ageing Ingredient of the Year Award in 2024 and its nomination as a finalist for the Innovation in Women's Health Award in 2025. The award comes at a critical juncture in healthcare, as the focus shifts from simply extending lifespan to enhancing healthspan, maintaining good health and well-being throughout life.

Tsuyoshi Takakuwa, Head of Marketing and Sales (APAC) for Kaneka's Supplemental Nutrition Business Division, expressed his gratitude for the recognition. "We are honored to receive this award," Takakuwa said. "It is a testament to the hard work of our team and the dedication of our customers and partners who continue to support our mission of advancing understanding of Ubiquinol and mitochondrial health worldwide."

Kazuki Takita, Assistant Manager of Marketing and Sales (APAC) for Kaneka Ubiquinol™, elaborated on the company's vision: "Our goal is to support healthspan from conception to old age, and we are committed to combining decades of research with scientific education and collaboration to provide global health solutions."

The award was presented based on the wealth of scientific evidence supporting Ubiquinol and its commercial success in the region, according to Gary Scattergood, Managing Director Asia for William Reed, the publisher of NutraIngredients Asia. "The judges were impressed by the robust scientific data and the impressive advocacy from medical and healthcare professionals," Scattergood said.

Ubiquinol, a vital component of mitochondrial function, plays a crucial role in energy production and reducing cellular damage. Kaneka Corporation has been at the forefront of Ubiquinol research for over 50 years, leveraging its unique, patented fermentation process to produce a high-quality, clinically tested ingredient.

"The healthspan movement is gaining momentum, and Kaneka Ubiquinol™ is at the heart of this movement," said Takita. "Our mission is to support healthspan by providing evidence-based solutions for mitochondrial health, cardiovascular health, cognition, and overall well-being."

Kaneka Ubiquinol™ is recognized globally for its commitment to quality and sustainability. The company boasts a long list of certifications, including HALAL, GRAS, HACCP, NDI, KOSHER, GMP, ISO 14001, ISO 22000, Non-GMO, Non-Animal Origin, and OSHMS, ensuring that its product meets the highest standards.

The company's accolades include not only the Healthspan Award but also the Vitafoods Europe Innovation Award for Most Innovative Consumer-Ready Nutraceutical Finished Product, a Tmall Global Marketing Innovation Award, and a Forbes Packaging Marketing Award, among others.

"Receiving multiple accolades is a clear indicator of our commitment to innovation and our dedication to improving healthspan," said Takita. "We will continue to work with our partners and customers to provide the best possible health solutions."

Kaneka Corporation's ongoing research and development efforts, coupled with its commitment to quality and sustainability, underscore its leadership in the global healthspan movement.